Asymmetric total synthesis of polycyclic xanthenes and discovery of a WalK activator active against MRSA.
Min-Jing ChengYan-Yi WuHao ZengTian-Hong ZhangYan-Xia HuShi-Yi LiuRui-Qin CuiChun-Xia HuQuan-Ming ZouChuang-Chuang LiWen-Cai YeWei HuangLei WangPublished in: Nature communications (2024)
The development of new antibiotics continues to pose challenges, particularly considering the growing threat of multidrug-resistant Staphylococcus aureus. Structurally diverse natural products provide a promising source of antibiotics. Herein, we outline a concise approach for the collective asymmetric total synthesis of polycyclic xanthene myrtucommulone D and five related congeners. The strategy involves rapid assembly of the challenging benzopyrano[2,3-a]xanthene core, highly diastereoselective establishment of three contiguous stereocenters through a retro-hemiketalization/double Michael cascade reaction, and a Mitsunobu-mediated chiral resolution approach with high optical purity and broad substrate scope. Quantum mechanical calculations provide insight into stereoselective construction mechanism of the three contiguous stereocenters. Additionally, this work leads to the discovery of an antibacterial agent against both drug-sensitive and drug-resistant S. aureus. This compound operates through a unique mechanism that promotes bacterial autolysis by activating the two-component sensory histidine kinase WalK. Our research holds potential for future antibacterial drug development.
Keyphrases
- drug resistant
- multidrug resistant
- staphylococcus aureus
- acinetobacter baumannii
- small molecule
- gram negative
- molecular dynamics
- methicillin resistant staphylococcus aureus
- silver nanoparticles
- high throughput
- klebsiella pneumoniae
- signaling pathway
- biofilm formation
- monte carlo
- high resolution
- density functional theory
- nuclear factor
- current status
- high speed
- ionic liquid
- tyrosine kinase
- loop mediated isothermal amplification
- mass spectrometry
- inflammatory response
- wound healing
- adverse drug
- single cell
- quantum dots
- energy transfer
- cystic fibrosis